Authors

• Chris Labaki (ORCID: https://orcid.org/0000-0002-9584-8455)
• David Maj
• Audreylie Lemelin
• Devon J. Boyne (ORCID: https://orcid.org/0000-0001-6301-2429)
• J. Connor Wells (ORCID: https://orcid.org/0000-0001-7655-1405)
• Benoit Beuselinck (ORCID: https://orcid.org/0000-0001-7427-9102)
• Winson Y. Cheung (ORCID: https://orcid.org/0000-0002-3679-4290)
• Sumanta Kumar Pal (ORCID: https://orcid.org/0000-0002-1712-0848)
• T. Powles
• Toni K. Choueiri (ORCID: https://orcid.org/0000-0002-9201-3217)
• Matthew T. Warkentin (ORCID: https://orcid.org/0000-0001-8730-3511)
• Bernadett Szabados (ORCID: https://orcid.org/0000-0002-8786-0032)
• Rana R. McKay (ORCID: https://orcid.org/0000-0002-0581-7963)
• Bradley A. McGregor (ORCID: https://orcid.org/0000-0002-8298-0289)
• Kosuke null Takemura (ORCID: https://orcid.org/0000-0003-4321-6074)
• Luis Contreras (ORCID: https://orcid.org/0000-0003-4928-4545)
• Takeshi Yuasa (ORCID: https://orcid.org/0000-0002-8924-6730)
• Darren R. Brenner (ORCID: https://orcid.org/0000-0003-1305-2582)
• Lisa Ludwig (ORCID: https://orcid.org/0009-0001-1447-2717)
• Daniel Y.C. Heng

Institutions

• Harvard University (US)
• Queen Mary University of London (GB)
• University of Calgary (CA)
• Ipsen (France) (FR)
• Rega Institute for Medical Research (BE)
• University of California San Diego (US)
• Institute of Cancer Research (CA)
• VIB-KU Leuven Center for Cancer Biology (BE)
• Therapure Biopharma (Canada) (CA)
• City of Hope (US)
• Alberta Cancer Foundation (CA)
• Dana-Farber Cancer Institute (US)
• Japanese Foundation For Cancer Research (JP)
• KU Leuven (BE)

Publication Details

Journal

Clinical Genitourinary Cancer

Published

2025-09-10

DOI

https://doi.org/10.1016/j.clgc.2025.102431

Citations

2

Primary Topic

Renal cell carcinoma treatment

Type

article

Field-Weighted Citation Impact

3.04

Funders

• Ipsen Biopharmaceuticals
• Ipsen